Pages

Look Towards A New Future

May 21, 2012

Consumer Health in Colombia

Growth remains strong, but limited by contraband
Growth in consumer health remained strong in 2011, just slightly higher than the growth rate seen in 2010. Growth was fuelled by bad weather, but also by the continued growth of the economy and disposable incomes in general. However, contraband sales continued to limit growth. The regulatory agency INVIMA reacted with more inspections of retail outlets and greater communication about which products are not authorised to be sold in Colombia.

Bad weather boosts demand
Global warming and the climate phenomena El Niño and La Niña deteriorated the health of the population. The development of a viral flu accompanied by gastrointestinal complaints repeatedly affected much of the population, increasing their consumption of analgesics, cough, cold and allergy (hay fever) remedies and digestive remedies.

GlaxoSmithKline de Colombia maintains the lead in consumer health
GlaxoSmithKline de Colombia remained the leading company in consumer health in 2011. The brand Dolex achieved the leading position through strong advertising, and its success was also due to having different presentations adapted to different buyers’ financial capacity. Tecnoquímicas remained in second position, but saw strong growth in 2011 as a result of strategies developed specifically to take share from the brands Dolex and Advil. Its strategy was to develop packaging with similar characteristics, with mass media advertising and cheaper prices.

Healthfood shops see an increase in share
Parapharmacies/drugstores is losing share to the growing number of healthfood shops and larger drug shelves in supermarkets. Distribution channels compete with strategies such as customer loyalty through the web, and exclusive benefits for members in stores. Locatel opened 11 new stores in the country, and Farmatodo was one of the most active companies in the network, with 32,000 followers on Twitter.

Get Your Copy of Report @ http://www.reportsnreports.com/reports/160655-consumer-health-in-colombia.html  

Report Details :
Published: May 2012
Price: US $2400

    

Table of Contents
Consumer Health in Colombia - Industry Overview
EXECUTIVE SUMMARY
Growth remains strong, but limited by contraband
Bad weather boosts demand
GlaxoSmithKline de Colombia maintains the lead in consumer health
Healthfood shops see an increase in share
Price control could limit forecast growth
KEY TRENDS AND DEVELOPMENTS
Overweight and obese population increasing
High levels of stress are felt in large cities
Self-medication is a popular practice in Colombia
Colombian government commits to biotechnological development
Demographic changes impact consumer health
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 2 Life Expectancy at Birth 2006-2011
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2006-2011
Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 5 Consumer Health Company Shares 2007-2011
Table 6 Consumer Health Brand Shares 2008-2011
Table 7 Penetration of Private Label by Category 2006-2011
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC registration and classification
Delisting or de-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
Summary 1 OTC Switches 2009-2011